RVT 101

3 Long Shots Biotech Companies Are Working On
Motley Fool
Sat, 07/11/15 - 10:27 am
biotech
Alzheimer's disease
Parkinson's Disease
Axovant Sciences
RVT 101
GSK
Biogen
aducanumab
Prothena
PRX-002